Attached files
| file | filename |
|---|---|
| 10-K - FORM 10-K - RESPONSE BIOMEDICAL CORP | rpbif20151231_10k.htm |
| EX-31.1 - EXHIBIT 31.1 - RESPONSE BIOMEDICAL CORP | ex31-1.htm |
| EX-32.1 - EXHIBIT 32.1 - RESPONSE BIOMEDICAL CORP | ex32-1.htm |
| EX-23.1 - EXHIBIT 23.1 - RESPONSE BIOMEDICAL CORP | ex23-1.htm |
| EX-31.2 - EXHIBIT 31.2 - RESPONSE BIOMEDICAL CORP | ex31-2.htm |
| EX-10.37 - EXHIBIT 10.37 - RESPONSE BIOMEDICAL CORP | ex10-37.htm |
| EX-21 - EXHIBIT 21 - RESPONSE BIOMEDICAL CORP | ex21.htm |
Exhibit 32.2
CERTIFICATION PURSUANT TO
18 U.S.C SECTION 1350,
AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
In connection with the Annual Report on Form 10-K of Response Biomedical Corp. (the “Company”) for the period ended December 31, 2015, as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, William J. Adams, Chief Financial Officer of the Company, certify, pursuant to 18 U.S.C. section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that to the best of my knowledge:
|
1. |
The Report fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934; and |
|
2. |
The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company. |
|
By: |
/s/ William J. Adams | |
|
William J. Adams | ||
|
Chief Financial Officer |
Dated: March 24, 2016